Table 5.
Anchors suggested for the MI phenotype and T2DM phenotype
| Myocardial Infarction (MI) | Type 2 diabetes mellitus (T2DM) | ||||||
|---|---|---|---|---|---|---|---|
| Source | importance / rank | concept_name | Source | Importance / rank | concept_name | ||
| obs | 1.9036 | 1 | Renal function | lab | 0.5637 | 1 | Serum HDL/non-HDL cholesterol ratio measurement |
| obs | 1.8554 | 2 | Every eight hours | lab | 0.5466 | 2 | Glucose measurement |
| obs | 1.7831 | 3 | Chest CT | obs | 0.5328 | 3 | Lipid panel |
| obs | 1.7108 | 4 | Cataract | obs | 0.5156 | 4 | Asthma |
| obs | 1.6386 | 5 | Hypercholesterolemia | obs | 0.4984 | 5 | Diabetes mellitus |
| obs | 1.5663 | 6 | Osteopenia | lab | 0.4778 | 6 | Hyaline casts |
| obs | 1.4699 | 7 | Palpitations | obs | 0.4675 | 7 | Pulmonary edema |
| obs | 1.3735 | 8 | Commode | obs | 0.4366 | 8 | Obesity |
| obs | 1.3012 | 9 | Tightness sensation quality | obs | 0.4228 | 9 | Hypoglycemia |
| obs | 1.253 | 10 | Afternoon | obs | 0.3987 | 10 | Metformin |
| obs | 1.012 | 11 | Deficiency | obs | 0.3816 | 11 | Duplex |
| drugEx | 0.8916 | 12 | ferrous sulfate | obs | 0.3712 | 12 | Palpitations |
| drugEx | 0.7711 | 13 | Dobutamine | visit | 0.3541 | 13 | Obesity |
| obs | 0.7229 | 14 | Fibrovascular | lab | 0.3334 | 14 | Glucose |
| lab | 0.5542 | 15 | Sodium [Moles/volume] in Blood | lab | 0.3059 | 15 | Hemoglobin A1c |
| drugEx | 0.4819 | 16 | clopidogrel | obs | 0.2784 | 16 | Subclavicular approach |
| lab | 0.3855 | 17 | Lactic acid measurement | obs | 0.2303 | 17 | Colonoscopy |
| obs | 0.3133 | 18 | Pressure ulcer | obs | 0.2131 | 18 | Cholesterol |
| drugEx | 0.1928 | 19 | zolpidem | drugEx | 0.1925 | 19 | Insulin, Regular, Human |
| obs | 0.0964 | 20 | Aspirin 81 MG Enteric Coated Tablet | drugEx | 0.0206 | 20 | Oxycodone |